Oliver Distler

52.8k total citations · 9 hit papers
610 papers, 25.5k citations indexed

About

Oliver Distler is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Oliver Distler has authored 610 papers receiving a total of 25.5k indexed citations (citations by other indexed papers that have themselves been cited), including 441 papers in Pathology and Forensic Medicine, 186 papers in Pulmonary and Respiratory Medicine and 131 papers in Molecular Biology. Recurrent topics in Oliver Distler's work include Systemic Sclerosis and Related Diseases (419 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (149 papers) and Dermatologic Treatments and Research (107 papers). Oliver Distler is often cited by papers focused on Systemic Sclerosis and Related Diseases (419 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (149 papers) and Dermatologic Treatments and Research (107 papers). Oliver Distler collaborates with scholars based in Switzerland, Germany and United States. Oliver Distler's co-authors include Jörg H. W. Distler, Steffen Gay, Georg Schett, Clara Dees, Yannick Allanore, Christian Beyer, Renate E. Gay, Beat A. Michel, Ulf Müller‐Ladner and Alfiya Akhmetshina and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Oliver Distler

581 papers receiving 25.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

2019 956 citations Oliver Distler, Masataka Kuwana et al. profile →
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

2012 679 citations Alfiya Akhmetshina, Katrin Palumbo et al. profile →
Systemic sclerosis

2015 575 citations Yannick Allanore, Oliver Distler et al. profile →
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

2013 541 citations Oliver Distler, Dinesh Khanna et al. Annals of the Rheumatic Diseases profile →
Synovial fibroblasts: key players in rheumatoid arthritis

2006 506 citations Oliver Distler, Steffen Gay et al. profile →
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

2017 438 citations Oliver Distler et al. profile →
MicroRNA‐29, a key regulator of collagen expression in systemic sclerosis

2010 434 citations Britta Maurer, Astrid Jüngel et al. profile →
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

2017 320 citations Dinesh Khanna, Yannick Allanore et al. profile →
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

2020 193 citations Anna‐Maria Hoffmann‐Vold, Yannick Allanore et al. Annals of the Rheumatic Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Oliver Distler	12.6k	7.9k	7.4k	5.3k	4.2k	610	25.5k
Christopher P. Denton	16.4k 1.3×	9.7k 1.2×	5.1k 0.7×	5.0k 0.9×	5.7k 1.4×	461	24.1k
Shinichi Sato	8.9k 0.7×	3.8k 0.5×	4.3k 0.6×	8.2k 1.5×	4.6k 1.1×	782	25.0k
John Varga	7.6k 0.6×	6.7k 0.8×	6.4k 0.9×	3.1k 0.6×	3.0k 0.7×	279	20.2k
Marco Matucci‐Cerinic	11.8k 0.9×	4.4k 0.6×	3.3k 0.5×	4.6k 0.9×	4.8k 1.2×	672	20.8k
É. Hachulla	7.6k 0.6×	8.3k 1.1×	3.4k 0.5×	4.3k 0.8×	2.3k 0.5×	677	22.4k
Sergio A. Jiménez	6.1k 0.5×	3.0k 0.4×	6.0k 0.8×	2.7k 0.5×	2.5k 0.6×	390	20.9k
Ulf Müller‐Ladner	5.0k 0.4×	2.1k 0.3×	3.8k 0.5×	4.2k 0.8×	2.0k 0.5×	495	16.9k
Thomas A. Medsger	20.7k 1.6×	7.9k 1.0×	4.3k 0.6×	10.0k 1.9×	6.9k 1.6×	229	43.1k
Manabu Fujimoto	5.7k 0.5×	2.4k 0.3×	3.3k 0.4×	6.8k 1.3×	2.9k 0.7×	486	17.7k
Maureen D. Mayes	9.3k 0.7×	4.0k 0.5×	1.8k 0.2×	3.2k 0.6×	3.2k 0.8×	227	14.3k

Countries citing papers authored by Oliver Distler

Since Specialization

Citations

This map shows the geographic impact of Oliver Distler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Distler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Distler more than expected).

Fields of papers citing papers by Oliver Distler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Distler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Distler. The network helps show where Oliver Distler may publish in the future.

Co-authorship network of co-authors of Oliver Distler

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Distler. A scholar is included among the top collaborators of Oliver Distler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Distler. Oliver Distler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Opitz, Lennart, Reto A. Schuepbach, Florian Brunner, et al.. (2024). Low back pain patients with Modic type 1 changes exhibit distinct bacterial and non-bacterial subtypes. SHILAP Revista de lepidopterología. 6(1). 100434–100434. 12 indexed citations

Hoffmann‐Vold, Anna‐Maria, Ishita Barua, Ana Maria Gheorghiu, et al.. (2024). POS0203 EVIDENCE-BASED EXPERT CONSENSUS DEFINITION OF ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS – A EUSTAR STUDY. Annals of the Rheumatic Diseases. 83. 331–332.

Distler, Oliver, et al.. (2024). Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal. The Journal of Rheumatology. 51(11). 1060–1068. 2 indexed citations

Dobrotă, Rucsandra, Kim Fligelstone, A. Kennedy, et al.. (2024). Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis. RMD Open. 10(4). e004653–e004653.

Becker, Mike Oliver, Cosimo Bruni, Rucsandra Dobrotă, et al.. (2024). Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?. RMD Open. 10(3). e004333–e004333. 2 indexed citations

Aringer, Martin, Oliver Distler, Anna‐Maria Hoffmann‐Vold, et al.. (2024). Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases. RMD Open. 10(4). e004704–e004704. 4 indexed citations

Dobrotă, Rucsandra, Suzana Jordan, Nicoletta Del Papa, et al.. (2024). Dysregulation of circulating collagen turnover markers in very early systemic sclerosis. RMD Open. 10(2). e003306–e003306. 4 indexed citations

Spirig, José Miguel, Christoph J. Laux, Florian Brunner, et al.. (2023). Bone marrow stromal cells in Modic type 1 changes promote neurite outgrowth. Frontiers in Cell and Developmental Biology. 11. 1286280–1286280. 1 indexed citations

Micheroli, Raphael, Manouk de Hooge, Xenofon Baraliakos, et al.. (2023). Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry. Arthritis Research & Therapy. 25(1). 40–40. 2 indexed citations

10.

Fortuni, Federico, Anna‐Maria Hoffmann‐Vold, Ruxandra Jurcuţ, et al.. (2023). Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes. RMD Open. 9(4). e003380–e003380. 1 indexed citations

11.

Micheroli, Raphael, Kristina Bürki, Burkhard Möller, et al.. (2023). Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clinical Rheumatology. 42(9). 2377–2385. 5 indexed citations

12.

Gotschy, Alexander, Suzana Jordan, Christian T. Stoeck, et al.. (2022). Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis. European Heart Journal - Cardiovascular Imaging. 24(3). 373–382. 15 indexed citations

13.

Farshad, Mazda, et al.. (2022). Should Degenerated Intervertebral Discs of Patients with Modic Type 1 Changes Be Treated with Mesenchymal Stem Cells?. International Journal of Molecular Sciences. 23(5). 2721–2721. 11 indexed citations

14.

Laux, Christoph J., Agnieszka Karol, Frédéric Cornaz, et al.. (2022). Modic type 2 changes are fibroinflammatory changes with complement system involvement adjacent to degenerated vertebral endplates. JOR Spine. 6(1). e1237–e1237. 10 indexed citations

15.

Kuret, Tadeja, Katja Lakota, Saša Čučnik, et al.. (2021). Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis. International Journal of Molecular Sciences. 22(12). 6520–6520. 10 indexed citations

16.

Léger, Bertrand, Clara Dees, Christian Beyer, et al.. (2020). Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse. British Journal of Pharmacology. 177(18). 4296–4309. 20 indexed citations

17.

Koning, Roman I., Marcin Czepiel, Monika Baj‐Krzyworzeka, et al.. (2019). WNT3a and WNT5a Transported by Exosomes Activate WNT Signaling Pathways in Human Cardiac Fibroblasts. International Journal of Molecular Sciences. 20(6). 1436–1436. 68 indexed citations

18.

Khanna, Dinesh, et al.. (2014). SAR100842, an Antagonist of Lysophaphatidic Acid Receptor 1, As a Potential Treatment for Patients with Systemic Sclerosis: Results from a Phase 2a Study.. UCL Discovery (University College London). 3 indexed citations

19.

Dees, Clara, Alfiya Akhmetshina, Pawel Zerr, et al.. (2011). Platelet-derived serotonin links vascular disease and tissue fibrosis. The Journal of Experimental Medicine. 208(5). 961–972. 207 indexed citations

20.

Kurowska‐Stolarska, Mariola, J. Distler, Thomas Pap, et al.. (2004). The inhibitor of differentiation-2 (Id-2) induced by hypoxia promotes bone de radation in rheumatoid arthritis (RA). ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact